Summit Therapeutics Inc
For the period ended Dec 31, 2024. Filed Feb 24, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 24, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| SUMMIT THERAPEUTICS INC. | |
|---|---|
| By: | /s/ Robert W. Duggan |
| Name:Title: | Robert W. DugganCo-Chief Executive Officer and Executive Chairman (Principal Executive Officer) |
| By: | /s/ Mahkam Zanganeh |
| Name:Title: | Dr. Mahkam ZanganehCo-Chief Executive Officer, President and Director(Principal Executive Officer) |
| By: | /s/ Manmeet S. Soni |
| Name:Title: | Manmeet S. SoniChief Operating Officer, Chief Financial Officer and Director (Principal Financial Officer) |
Date: February 24, 2025
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Robert W. Duggan | Co-Chief Executive Officer and Executive Chairman (Principal Executive Officer) | February 24, 2025 |
| Robert W. Duggan | ||
| /s/ Mahkam Zanganeh | Co-Chief Executive Officer, President and Director(Principal Executive Officer) | February 24, 2025 |
| Dr. Mahkam Zanganeh | ||
| /s/ Manmeet S. Soni | Chief Operating Officer, Chief Financial Officer and Director(Principal Financial Officer) | February 24, 2025 |
| Manmeet S. Soni | ||
| /s/ Bhaskar Anand | Head of Finance and Chief Accounting Officer(Principal Accounting Officer) | February 24, 2025 |
| Bhaskar Anand | ||
| /s/ Robert F. Booth | Director | February 24, 2025 |
| Dr. Robert F. Booth | ||
| /s/ Alessandra Cesano | Director | February 24, 2025 |
| Dr. Alessandra Cesano | ||
| /s/ Kenneth Clark | Director | February 24, 2025 |
| Kenneth Clark | ||
| /s/ Jeff Huber | Director | February 24, 2025 |
| Jeff Huber | ||
| /s/ Mostafa Ronaghi | Director | February 24, 2025 |
| Mostafa Ronaghi | ||
| /s/ Yu Xia | Director | February 24, 2025 |
| Dr. Yu Xia | ||
| Summit Therapeutics Inc. | Page |
|---|---|
| Index to the Financial Statements | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 238) | 88 |
| Consolidated Balance Sheets | 90 |
| Consolidated Statements of Operations and Comprehensive Loss | 91 |
| Consolidated Statements of Stockholders' Equity | 92 |
| Consolidated Statements of Cash Flows | 93 |
| Notes to the Consolidated Financial Statements | 94 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.